Case Studies of HIT in Cardiovascular Medicine

We present three clinical cases that illustrate some of the key features of the diagnosis and management of immune-mediated heparin-induced thrombocytopenia (HIT). The importance of having a high clinical suspicion for HIT in the appropriate clinical setting is emphasized. Early therapeutic decisions should be based on a clinical diagnosis, with laboratory tests serving as confirmation. Low-molecular-weight and unfractionated heparins are to be strictly avoided in patients with HIT. Identification bracelets or necklaces may be useful to reduce inappropriate administration of these agents to patients with HIT presenting with acute coronary syndromes.

KEYWORDS

Heparin-induced thrombocytopenia - HIT - clinical diagnosis - laboratory tests - treatment

REFERENCES

• 1 Brieger D B, Mak K H, Kottke-Marchant K, Topol E J. Heparin-induced thrombocytopenia.  J Am Coll Cardiol. 1998;  31 1449-1459
• 2 Warkentin T E, Greinacher A. Heparin-Induced Thrombocytopenia. 2nd ed. New York; Marcel Dekker, Inc 2001 59
• 3 Sheth S B, DiCicco R A, Hursting M J, Montague T, Jorkasky D K. Interpreting the international normalized ratio (INR) in individuals receiving argatroban and warfarin.  Thromb Haemost. 2001;  85 435-440
• 4 Yoder M, Edwards R F. Reversible thrombocytopenia associated with eptifibatide.  Ann Pharmacother. 2002;  36 628-630
• 5 Jubelirer S J, Koenig B A, Bates M C. Acute profound thrombocytopenia following C7E3 fab (abciximab) therapy: case reports, review of literature and implications for therapy.  Am J Hematol. 1999;  61 205-208
• 6 Warkentin T E, Kelton J G. Temporal aspects of heparin-induced thrombocytopenia.  N Engl J Med. 2001;  344 1286-1292
• 7 Giugliano R P. Drug-induced thrombocytopenia: is it a serious concern for glycoprotein IIb/IIIa receptor inhibitors?.  J Thromb Thrombolysis. 1998;  5 191-202
• 8 Warkentin T E, Levine M N, Hirsh J et al.. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin.  N Engl J Med. 1995;  332 1330-1335